Ivermectin dosing based on physical appearance
- 1 January 1995
- journal article
- research article
- Published by Springer Nature in International Ophthalmology
- Vol. 18 (4) , 215-219
- https://doi.org/10.1007/bf00951800
Abstract
Ivermectin is a safe and effective microfilaricide which has been shown to have a beneficial impact on some onchocercal eye lesions. Current requirements for the distribution of ivermectin are that patients be weighed, and that their dose be determined according to their weight. This requirement increases the cost of distributing the drug to communities in need of treatment and, when scales breakdown, may lead to the suspension of distribution. Data are presented on a simple, alternative method of dose assessment based on the physical appearance of the patient. Fifteen assessors achieved an overall level of agreement with the weight-based schedule of 86% on a sample of 6420 patients. The level of agreement varied between assessors, from 73% to 95%. About 6% of the population would have received doses outside the range of the current weight-based schedule. We believe that the current insistence that each individual's dose of ivermectin be determined by weighing will hamper efforts to distribute the drug to those most in need of it and that our data indicate that workers can be trained to distribute ivermectin safely without weighing every individual. We would welcome confirmation of our findings from other populations.Keywords
This publication has 11 references indexed in Scilit:
- Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasisThe Lancet, 1993
- Simplified dose schedule of ivermectinThe Lancet, 1993
- Ivermectin dose assessment without weighing scales.1993
- Effects of repeated doses of ivermectin on ocular onchocerciasis: community-based trial in Sierra LeoneThe Lancet, 1991
- Tolerance of single high-dose ivermectin for treatment of lymphatic filariasisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1991
- Changes in ocular onchocerciasis four and twelve months after community-based treatment with ivermectin in a holoendemic onchocerciasis focusTransactions of the Royal Society of Tropical Medicine and Hygiene, 1990
- Ophthalmological results from a placebo controlled comparative 3-dose ivermectin study in the treatment of onchocerciasis.1989
- Ivermectin Treatment of Patients with Severe Ocular OnchocerciasisThe American Journal of Tropical Medicine and Hygiene, 1989
- The chemotherapy of onchocerciasis XI A double-blind comparative study of ivermectin, diethylcarbamazine and placebo in human onchocerciasis in Northern GhanaPathogens and Global Health, 1986
- Treatment of OnchocerciasisArchives of Ophthalmology (1950), 1986